Pozelimab (REGN3918), a fully human IgG4 monoclonal antibody, is designed to target and bind with high affinity to both C5 and its variants, effectively inhibiting complement-mediated hemolysis. It holds potential for research into complement-mediated di
CAS Number:
[2096328-94-6]
* VAT and and shipping costs not included. Errors and price changes excepted